Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
SLC47A1 |
MATE1 |
Losartan |
250 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE1 |
Wittwer, 2013 |
SLC22A8 |
OAT3 |
Losartan |
0.36 |
|
6-carboxyfluorescein |
HEK293-OAT3 |
Zou, 2021 |
SLC22A6 |
OAT1 |
Losartan |
11.4 |
|
6-carboxyfluorescein |
HEK293-OAT1 |
Zou, 2021 |
ABCG2 |
BCRP, MXR |
Losartan |
4.8 |
|
Cholecystokinin octapeptide |
BCRP membrane vesicles |
Yee, 2021 |
SLCO2B1 |
OATP2B1, OATP-B |
Losartan |
8 |
|
Dibromofluorescein |
HEK293-OATP2B1 |
Unger, 2020 |
ABCC4 |
MRP4 |
Losartan |
34.1 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC3 |
MRP3 |
Losartan |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC15A1 |
PEPT1 |
Losartan |
|
24 |
Glycylsarcosine |
Caco-2 |
Knutter, 2009 |
SLC15A1 |
PEPT1 |
Losartan |
|
52 |
Glycylsarcosine |
HeLa-PEPT1 |
Knutter, 2009 |
SLC15A2 |
PEPT2 |
Losartan |
|
2.4 |
Glycylsarcosine |
HeLa-PEPT2 |
Knutter, 2009 |
ABCB11 |
BSEP |
Losartan |
8.53 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC22A12 |
URAT1 |
Losartan |
|
0.0077 |
Uric acid |
URAT1-expressing oocytes |
Iwanaga, 2007 |
ABCC4 |
MRP4 |
Losartan |
1.5 |
|
Uric acid |
MRP4-expressing Sf9 vesicles |
Sato, 2008 |
SLC22A11 |
OAT4 |
Losartan |
18 |
|
Uric acid |
HEK293-OAT4 |
Sato, 2008 |
SLC22A6 |
OAT1 |
Losartan |
12 |
|
Uric acid |
HEK293-OAT1 |
Sato, 2008 |
SLC22A8 |
OAT3 |
Losartan |
1.6 |
|
Uric acid |
HEK293-OAT3 |
Sato, 2008 |
SLC22A12 |
URAT1 |
Losartan |
570.5 |
|
Uric acid |
HEK293-URAT1 |
Uetake, 2010 |
No drug-drug interaction information.